This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Logo

A Woman Suffered From Leukocytopenia and Widespread Migration After Polyacrylamide Hydrogel (PAAG) Injection in Epicranial Aponeurosis

Sponsored by Duo Zhang

About this trial

Last updated 14 years ago

Study ID

zhangduo

Status

Completed

Type

Observational

Placebo

No

Accepting

50 to 50 Years
Female

Trial Timing

Started 15 years ago

What is this trial about?

Polyacrylamide hydrogel (PAAG) has been used as an injectable filler for soft tissue augmentation in different parts of the body , such as face, breast , or even penis for more than a decade . However, there are never reports about the application of a large amount of PAAG in epicranial aponeurosis to change the contour of the upper cranium accompanied with leukocytopenia. This fancy application turned out to be a disaster for the women who suffered from leukocytopenia , widespread migration of PAAG, recurrent swelling of the affected tissues and temporal pain changing with the temperature and the facial expression .

What are the participation requirements?

Inclusion Criteria

* PAAG injected into bilateral temporal epicranial aponeurosis

Exclusion Criteria

* PAAG injected into other parts of the body